HDL Cholesterol May Protect Against Brain Atrophy
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 7, 2025 -- High-density lipoprotein (HDL) cholesterol may help conserve healthy brain matter in middle-aged adults, according to a study published online Oct. 18 in the Journal of Clinical Medicine.
John M. Giacona, Ph.D., from University of Texas Southwestern Medical Center in Dallas, and colleagues examined associations between HDL measures and brain structure and function. The analysis included data from 1,826 adult participants (47 percent Black; mean age, 51.0 years) in the Dallas Heart Study.
The researchers found that higher HDL cholesterol efflux capacity and small HDL particle (HDL-P) concentration were positively associated with higher whole-brain grey matter volume normalized to total cranial volume (GMV/TCV) when adjusting for traditional risk factors such as age, smoking status, time spent in daily physical activity, and education level (β = 0.078 and 0.063, respectively). There were no associations between HDL measures and white matter hyperintensities or Montreal Cognitive Assessment scores. These associations between HDL cholesterol efflux capacity and small HDL-P with GMV/TCV were not modified by apolipoprotein E-ε4 status or race/ethnicity.
"Having higher GMV in midlife may aid in preventing cognitive decline associated with brain atrophy as part of normal aging in late life," the authors write. "Additional studies are needed to explore the potential neuroprotective functions of HDL."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Avoidable All-Cause Hospitalization, ED Visits Common in Nursing Homes
MONDAY, Aug. 4, 2025 -- Among severely impaired and terminally ill nursing home (NH) residents, all-cause hospitalizations (ACH) and emergency department visits without...
Average Time to Diagnosis Is 3.5 Years Across All Types of Dementia
FRIDAY, Aug. 1, 2025 -- The mean time to diagnosis (TTD) for dementia is 3.5 years across all types of dementia, according to a review published online July 27 in the...
Intranasal Administration of PET Radiotracer Delivers Insulin to Multiple Brain Regions
THURSDAY, July 31, 2025 -- Intranasal administration of [68Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.